-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Cytek Biosciences, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2020 to Q3 2024.
- Cytek Biosciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $7.05M, a 22.5% increase year-over-year.
- Cytek Biosciences, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $25.5M, a 22.4% increase year-over-year.
- Cytek Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $22M, a 32.9% increase from 2022.
- Cytek Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $16.6M, a 152% increase from 2021.
- Cytek Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $6.59M, a 978% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)